$BHAC
Focus Impact BH3 Acquisition Co

2024 Q2 Form 10-Q Financial Statement

#000114036124037143 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.370M
YoY Change 670.1%
Operating Profit -$1.370M
YoY Change -870.11%
Interest Expense -$47.77K
YoY Change -101.71%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.418M
YoY Change -154.28%
Income Tax $30.65K
% Of Pretax Income
Net Earnings -$1.449M
YoY Change -160.23%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.18
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.21K
YoY Change -69.29%
Cash & Equivalents $50.21K
Short-Term Investments
Other Short-Term Assets $2.870K
YoY Change
Inventory
Prepaid Expenses $2.869K
Receivables
Other Receivables
Total Short-Term Assets $538.8K
YoY Change 229.54%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $25.09M
YoY Change -52.0%
Other Assets
YoY Change
Total Long-Term Assets $25.09M
YoY Change -52.0%
TOTAL ASSETS
Total Short-Term Assets $538.8K
Total Long-Term Assets $25.09M
Total Assets $25.63M
YoY Change -51.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.523M
YoY Change 2668892.42%
Accrued Expenses $1.240M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $100.0K
YoY Change 58.5%
Long-Term Debt Due $27.50K
YoY Change
Total Short-Term Liabilities $6.961M
YoY Change 923.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.961M
Total Long-Term Liabilities $0.00
Total Liabilities $6.961M
YoY Change -20.27%
SHAREHOLDERS EQUITY
Retained Earnings -$5.767M
YoY Change -29.87%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.766M
YoY Change
Total Liabilities & Shareholders Equity $25.63M
YoY Change -51.13%

Cashflow Statement

Concept 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.449M
YoY Change -160.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$714.0K
YoY Change 146.28%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $108.5K
YoY Change -34.77%
Cash From Investing Activities $108.5K
YoY Change -34.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 78.11K
YoY Change -61.43%
NET CHANGE
Cash From Operating Activities -714.0K
Cash From Investing Activities 108.5K
Cash From Financing Activities 78.11K
Net Change In Cash -527.4K
YoY Change -768.61%
FREE CASH FLOW
Cash From Operating Activities -$714.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Focus Impact BH3 Acquisition Company
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2249068
dei Entity Address Address Line1
EntityAddressAddressLine1
1345 Avenue of the Americas, 33rd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10105
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
213-0243
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 us-gaap Cash
Cash
50205
CY2023Q4 us-gaap Cash
Cash
631337
CY2024Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
485705
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
138277
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2869
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11306
CY2024Q2 us-gaap Assets Current
AssetsCurrent
538779
CY2023Q4 us-gaap Assets Current
AssetsCurrent
780920
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
25089733
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
24554804
CY2024Q2 us-gaap Assets
Assets
25628512
CY2023Q4 us-gaap Assets
Assets
25335724
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3523067
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
157789
CY2024Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
283933
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
283933
CY2024Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
955617
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
955617
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1432000
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1074000
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
100000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
638431
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
346353
CY2024Q2 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
27500
CY2023Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
64750
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6960548
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2882442
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
24433968
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5766578
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1552615
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5766004
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1552041
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25628512
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25335724
us-gaap Net Income Loss
NetIncomeLoss
2484055
bhac Interest Income From Trust Account
InterestIncomeFromTrustAccount
643393
bhac Interest Income From Trust Account
InterestIncomeFromTrustAccount
1164678
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
244582
bhac Change In Fair Value Of Share Subscription Agreement
ChangeInFairValueOfShareSubscriptionAgreement
-110322
bhac Change In Fair Value Of Share Subscription Agreement
ChangeInFairValueOfShareSubscriptionAgreement
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
358000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1750620
bhac Gain Loss In Fair Value Of Convertible Promissory Notes Net
GainLossInFairValueOfConvertiblePromissoryNotesNet
0
bhac Gain Loss In Fair Value Of Convertible Promissory Notes Net
GainLossInFairValueOfConvertiblePromissoryNotesNet
416974
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-8437
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3365278
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
132
bhac Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
-20050
bhac Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1102346
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-689733
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
104383147
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
108464
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
229513
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
910000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
100000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
350000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
86636
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
300000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
49386
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
412750
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
610000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-581132
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
149780
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
631337
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13715
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50205
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163495
bhac Change In Non Cash Transaction Value Of Common Stock Subject To Possible Redemption
ChangeInNonCashTransactionValueOfCommonStockSubjectToPossibleRedemption
428645
bhac Change In Non Cash Transaction Value Of Common Stock Subject To Possible Redemption
ChangeInNonCashTransactionValueOfCommonStockSubjectToPossibleRedemption
0
bhac Polar Share Subscription Agreement
PolarShareSubscriptionAgreement
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align: justify; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Concentration of Credit Risk</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts or investment accounts in a financial institution, which at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.</div>
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001851612
bhac Number Of Days Prior In Initial Business Combination
NumberOfDaysPriorInInitialBusinessCombination
P2D
bhac Period To Redeem Public Shares If Business Combination Is Not Completed Within Initial Combination Period
PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
P10D
CY2023Q3 us-gaap Notes Payable Related Party Type Extensible Enumeration
NotesPayableRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#InvestorMember
dei Entity File Number
EntityFileNumber
001-40868
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
24005323
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1370395
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
177949
us-gaap Operating Expenses
OperatingExpenses
4016639
us-gaap Operating Expenses
OperatingExpenses
603635
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1370395
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-177949
us-gaap Operating Income Loss
OperatingIncomeLoss
-4016639
us-gaap Operating Income Loss
OperatingIncomeLoss
-603635
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
323094
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
592837
us-gaap Investment Income Interest
InvestmentIncomeInterest
643393
us-gaap Investment Income Interest
InvestmentIncomeInterest
1164678
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
358000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1954680
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
358000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1750620
CY2024Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
1476
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Gain Loss On Investments
GainLossOnInvestments
2655
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
CY2024Q2 bhac Change In Fair Value Of Note Payable
ChangeInFairValueOfNotePayable
-14336
CY2023Q2 bhac Change In Fair Value Of Note Payable
ChangeInFairValueOfNotePayable
0
bhac Change In Fair Value Of Note Payable
ChangeInFairValueOfNotePayable
-110322
bhac Change In Fair Value Of Note Payable
ChangeInFairValueOfNotePayable
0
CY2024Q2 bhac Gain Loss In Fair Value Of Convertible Promissory Notes Net
GainLossInFairValueOfConvertiblePromissoryNotesNet
0
CY2023Q2 bhac Gain Loss In Fair Value Of Convertible Promissory Notes Net
GainLossInFairValueOfConvertiblePromissoryNotesNet
243274
bhac Gain Loss In Fair Value Of Convertible Promissory Notes Net
GainLossInFairValueOfConvertiblePromissoryNotesNet
0
bhac Gain Loss In Fair Value Of Convertible Promissory Notes Net
GainLossInFairValueOfConvertiblePromissoryNotesNet
416974
CY2024Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-47766
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2790791
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
177726
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3332272
CY2024Q2 bhac Income Loss From Continuing Operations Before Income Taxes Excluding The Impact Of Fin48 Liability
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExcludingTheImpactOfFIN48Liability
-1418161
CY2023Q2 bhac Income Loss From Continuing Operations Before Income Taxes Excluding The Impact Of Fin48 Liability
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExcludingTheImpactOfFIN48Liability
2612842
bhac Income Loss From Continuing Operations Before Income Taxes Excluding The Impact Of Fin48 Liability
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExcludingTheImpactOfFIN48Liability
-3838913
bhac Income Loss From Continuing Operations Before Income Taxes Excluding The Impact Of Fin48 Liability
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExcludingTheImpactOfFIN48Liability
2728637
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30645
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
207539
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114649
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
244582
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1448806
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2405303
us-gaap Net Income Loss
NetIncomeLoss
-3953562
us-gaap Net Income Loss
NetIncomeLoss
2484055
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1552041
CY2024Q1 bhac Redeemable Common Stock Accretion To Redemption Value
RedeemableCommonStockAccretionToRedemptionValue
358656
CY2024Q1 bhac Polar Share Subscription Agreement
PolarShareSubscriptionAgreement
120592
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2504756
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-4294861
CY2024Q2 bhac Redeemable Common Stock Accretion To Redemption Value
RedeemableCommonStockAccretionToRedemptionValue
69989
CY2024Q2 bhac Polar Share Subscription Agreement
PolarShareSubscriptionAgreement
47652
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1448806
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5766004
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10016184
CY2023Q1 bhac Redeemable Common Stock Accretion To Redemption Value
RedeemableCommonStockAccretionToRedemptionValue
1622652
CY2023Q1 bhac Deemed Contribution By Former Sponsor
DeemedContributionByFormerSponsor
227424
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
78752
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-11332660
CY2023Q2 bhac Redeemable Common Stock Accretion To Redemption Value
RedeemableCommonStockAccretionToRedemptionValue
182025
CY2023Q2 bhac Deemed Contribution By Former Sponsor
DeemedContributionByFormerSponsor
202509
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2405303
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-8906873
us-gaap Net Income Loss
NetIncomeLoss
-3953562
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
327378
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
86230
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
104153634
bhac Proceeds From Trust Account For Payment Of Taxes
ProceedsFromTrustAccountForPaymentOfTaxes
108464
bhac Proceeds From Trust Account For Payment Of Taxes
ProceedsFromTrustAccountForPaymentOfTaxes
0
bhac Polar Share Subscription Agreement
PolarShareSubscriptionAgreement
168244
CY2023Q4 bhac Stock Conversion Ratio
StockConversionRatio
1
CY2023Q4 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
2700563
CY2023Q4 bhac Number Of Shares Transferred By New Sponsor To Non Redemption Holders
NumberOfSharesTransferredByNewSponsorToNonRedemptionHolders
389359
CY2024Q2 us-gaap Cash
Cash
50205
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
25089733
CY2024Q2 bhac Working Capital Deficit
WorkingCapitalDeficit
6421769
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align: justify; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The preparation of these unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the derivative warrant liabilities. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</div>
CY2024Q2 us-gaap Cash
Cash
50205
CY2023Q4 us-gaap Cash
Cash
631337
bhac Holding Period For Transfer Assignment Or Sale Of Founder Shares
HoldingPeriodForTransferAssignmentOrSaleOfFounderShares
P1Y
CY2024Q2 us-gaap Share Price
SharePrice
12
bhac Threshold Trading Days
ThresholdTradingDays
P20D
bhac Threshold Consecutive Trading Days
ThresholdConsecutiveTradingDays
P30D
bhac Period After Initial Business Combination
PeriodAfterInitialBusinessCombination
P150D
CY2023Q4 us-gaap Share Price
SharePrice
3.13
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
156500
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200000000
CY2023Q4 bhac Excess Of Fair Value To Be Received
ExcessOfFairValueToBeReceived
156300
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
988402
CY2023Q4 bhac Working Capital Loan Option
WorkingCapitalLoanOption
0
CY2024Q2 bhac Working Capital Loan Option
WorkingCapitalLoanOption
0
CY2023Q4 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
335259
CY2023Q4 us-gaap Notes Payable
NotesPayable
64749
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
64749
CY2024Q2 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
27500
CY2024Q2 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
27500
CY2023Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
64750
CY2023 bhac Fair Value Of Non Redemption Agreements
FairValueOfNonRedemptionAgreements
1230000
CY2024Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
1200000
bhac Capital Contribution Repaid Period
CapitalContributionRepaidPeriod
P5D
bhac Common Stock Issued For Each Dollar Of Capital Contribution
CommonStockIssuedForEachDollarOfCapitalContribution
1
CY2024Q2 bhac Change In Fair Value Of Note Payable
ChangeInFairValueOfNotePayable
-14336
bhac Change In Fair Value Of Note Payable
ChangeInFairValueOfNotePayable
-110322
CY2024Q2 bhac Value Of Shares Issuable As Of The Execution Date Of Cma Contracts
ValueOfSharesIssuableAsOfTheExecutionDateOfCMAContracts
312600
CY2024Q2 bhac Additional Capital Market Advisor Liability Current
AdditionalCapitalMarketAdvisorLiabilityCurrent
3500000
CY2024Q2 bhac Percentage Of Deferred Cma Fees
PercentageOfDeferredCMAFees
0.04
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
955617
CY2024Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
955617
CY2024Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
283933
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1448806
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2405303
us-gaap Net Income Loss
NetIncomeLoss
-3953562
us-gaap Net Income Loss
NetIncomeLoss
2484055
CY2024Q2 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
69989
CY2023Q2 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
182025
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
428645
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1804677
CY2024Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-1518795
CY2023Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
2223278
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-4382207
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
679378
CY2024Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.1
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
100000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
bhac Stock Conversion Ratio
StockConversionRatio
1
CY2024Q2 bhac Stock Conversion As Converted Percentage
StockConversionAsConvertedPercentage
0.20
bhac Period To Exercise Warrants After Business Combination
PeriodToExerciseWarrantsAfterBusinessCombination
P30D
bhac Period To Exercise Warrants After Closing Of Initial Public Offering
PeriodToExerciseWarrantsAfterClosingOfInitialPublicOffering
P12M
bhac Period For Registration Statement To Become Effective
PeriodForRegistrationStatementToBecomeEffective
P60D
CY2024Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
bhac Period To File Registration Statement After Initial Business Combination
PeriodToFileRegistrationStatementAfterInitialBusinessCombination
P20D
bhac Number Of Demands That Can Be Made
NumberOfDemandsThatCanBeMade
3
bhac Underwriting Fee Discount Percentage
UnderwritingFeeDiscountPercentage
0.02
bhac Underwriting Discount
UnderwritingDiscount
4600000
bhac Underwriter Deferred Fee Discount Percentage
UnderwriterDeferredFeeDiscountPercentage
0.035
CY2024Q2 bhac Deferred Underwriting Commissions
DeferredUnderwritingCommissions
8100000
CY2023Q4 bhac Gain Recognized From Waiver Of Underwriting Discount
GainRecognizedFromWaiverOfUnderwritingDiscount
8100000
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
bhac-20240630_cal.xml Edgar Link unprocessable
0001140361-24-037143-index-headers.html Edgar Link pending
0001140361-24-037143-index.html Edgar Link pending
0001140361-24-037143.txt Edgar Link pending
0001140361-24-037143-xbrl.zip Edgar Link pending
bhac-20240630.xsd Edgar Link pending
ef20030917_10q.htm Edgar Link pending
ef20030917_ex31-1.htm Edgar Link pending
ef20030917_ex31-2.htm Edgar Link pending
ef20030917_ex32-1.htm Edgar Link pending
ef20030917_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
bhac-20240630_def.xml Edgar Link unprocessable
bhac-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ef20030917_10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bhac-20240630_lab.xml Edgar Link unprocessable